In situ intestinal permeability and in vivo oral bioavailability of celecoxib in supersaturating self-emulsifying drug delivery system
- 839 Downloads
In order to characterize the in situ intestinal permeability and in vivo oral bioavailability of celecoxib (CXB), a poorly water-soluble cyclooxygenase (COX)-2 inhibitor, various formulations including the self-emulsifying drug delivery system (SEDDS) and supersaturating SEDDS (S-SEDDS) were compared. The S-SEDDS formulation was obtained by adding Soluplus as a precipitation inhibitor to SEDDS, composed of Capryol 90 as oil, Tween 20 as surfactant, and Tetraglycol as cosurfactant (1:4.5:4.5 in volume ratio). An in situ single pass intestinal perfusion study in rats was performed with CXB-dissolved solutions at a concentration of 40 μg/mL. The effective permeability (Peff) of CXB in the control solution (2.5 v/v% Tween 20-containing PBS) was 6.39 × 10−5 cm/s. The Peff value was significantly increased (P < 0.05) by the lipid-based formulation, yielding 1.5- and 2.9-fold increases for the SEDDS and S-SEDDS solutions, respectively, compared to the control solution. After oral administration of various formulations to rats at the equivalent dose of 100 mg/kg of CXB, the plasma drug level was measured by LC–MS/MS. The relative bioavailabilities of SEDDS and S-SEDDS were 263 and 355 %, respectively, compared to the CXB suspension as a reference. In particular, S-SEDDS revealed the highest Cmax and the smallest Tmax, indicating rapid and enhanced absorption with this formulation. This study illustrates the potential use of the S-SEDDS formulation in the oral delivery of poorly water-soluble compounds.
KeywordsCelecoxib SEDDS Supersaturation Soluplus Intestinal permeability Bioavailability
This research was supported by the Chung-Ang University Research Scholarship Grants in 2013.
- Arai, H., M. Murata, and J. Shinoda. 1971. The interaction between polymer and surfactant: the composition of the complex between polyvinylpyrrolidone and sodium alkyl sulfate as revealed by surface tension, dialysis, and solubilization. Journal of Colloid and Interface Science 37: 223–227.CrossRefGoogle Scholar
- Berggren, S., J. Hoogstraate, U. Fagerholm, and H. Lennernas. 2004. Characterization of jejunal absorption and apical efflux of ropivacaine, lidocaine and bupivacaine in the rat using in situ and in vitro absorption models. European Journal of Pharmaceutical Sciences 21: 553–560.PubMedCrossRefGoogle Scholar
- Chen, L., X. Sha, X. Jiang, Y. Chen, Q. Ren, and X. Fang. 2013. Pluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluation. International Journal of Nanomedicine 8: 73–84.PubMedCentralPubMedGoogle Scholar
- Guzman, H.R., M. Tawa, Z. Zhang, P. Ratanabanangkoon, P. Shaw, C.R. Gardner, H. Chen, J.P. Moreau, O. Almarsson, and J.F. Remenar. 2007. Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations. Journal of Pharmaceutical Sciences 96: 2686–2702.PubMedCrossRefGoogle Scholar
- Kang, M.J., H.S. Kim, H.S. Jeon, J.H. Park, B.S. Lee, B.K. Ahn, K.Y. Moon, and Y.W. Choi. 2012. In situ intestinal permeability and in vivo absorption characteristics of olmesartan medoxomil in self-microemulsifying drug delivery system. Drug Development and Industrial Pharmacy 38: 587–596.PubMedCrossRefGoogle Scholar
- Karlsson, J., and P. Artursson. 1991. A method for the determination of cellular permeability coefficients and aqueous boundary layer thickness in monolayers of intestinal epithelial (Caco-2) cells grown in permeable filter chambers. International Journal of Pharmaceutics 71: 55–64.CrossRefGoogle Scholar
- Paulson, S.K., M.B. Vaughn, S.M. Jessen, Y. Lawal, C.J. Gresk, B. Yan, T.J. Maziasz, C.S. Cook, and A. Karim. 2001. Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption. Journal of Pharmacology and Experimental Therapeutics 297: 638–645.PubMedGoogle Scholar
- Zakeri-Milani, P., M. Barzegar-Jalali, H. Tajerzadeh, Y. Azarmi, and H. Valizadeh. 2005. Simultaneous determination of naproxen, ketoprofen and phenol red in samples from rat intestinal permeability studies: HPLC method development and validation. Journal of Pharmaceutical and Biomedical Analysis 39: 624–630.PubMedCrossRefGoogle Scholar